The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

M. Meegdes, K.I.E. Ibragimova, D.J.A. Lobbezoo, I.J.H. Vriens, L.F.S. Kooreman, F.L.G. Erdkamp, M.W. Dercksen, B.E.P.J. Vriens, K.N.A. Aaldering, M.J.A.E. Pepels, L.M.H. van de Winkel, J. Tol, J.B. Heijns, A.J. van de Wouw, N.A.J.B. Peters, A. Hochstenbach-Waelen, M.L. Smidt, S.M.E. Geurts, V.C.G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry'. Together they form a unique fingerprint.

Keyphrases

INIS

Medicine and Dentistry

Neuroscience

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology